Citations

Showing 10 of 108081 citations.

Intercavernous Sinus Dural Arteriovenous Fistula Successfully Treated with Transvenous Embolization
Loumiotis, Ioannis , Cloft, Harry J. , Lanzino, Giuseppe

Mayo Clinic

Interventional Neuroradiology | January 11, 2017 | Volume: 17 | Issue: 2 | Pages: 208-211

10.1177/159101991101700211 | PMID 21696660 Get It

The venous sinuses commonly found in the margins of the diaphragm and sella are venous interconnections between the bilateral cavernous dural sinuses and are termed intercavernous communications or intercavernous sinuses. They form a venous ring, a single “circular sinus” that extends throughout the skull base. We report the first case to our knowledge of an intercavernous sinus fistula. We emphasize the importance of thorough knowledge of lesion characteristics before considering any interventional procedure. An 84-year-old woman presented with alarming progressive orbital symptoms for one month affecting her left eye. A cerebral angiogram showed an intercavernous sinus fistula supplied by internal and external carotid arterial branches. Transvenous embolization through retrograde catheterization of the right inferior petrosal sinus allowed complete coil occlusion of the lesion. Cerebral angiography confirmed the absence of residual blood flow through the fistula. This report represents the first case of an intercavernous sinus dural arteriovenous fistula successfully treated with transvenous embolization. A detailed awareness of the regional anatomy is essential for treatment approach and favorable outcomes.
Microtubule‐associated protein 1B: Novel paraneoplastic biomarker
Gadoth, Avi , Kryzer, Thomas J., Fryer, Jim, McKeon, Andrew , Lennon, Vanda A. , Pittock, Sean J. , Pittock, S J , McKeon, Andrew

Mayo Clinic

Annals of Neurology | January 11, 2017 | Volume: 81 | Issue: 2 | Pages: 266-277

10.1002/ana.24872 | PMID 28074593 Get It

ObjectiveTo report the identification of microtubule‐associated protein (MAP) 1B as the antigen of the previously described Purkinje cell cytoplasmic antibody type 2 (PCA‐2) antibody, its frequency, and clinical, oncological, and serological associations.MethodsArchival serum or cerebrospinal fluid (CSF) specimens were available from 96 of 118 consecutive PCA‐2‐IgG–seropositive patients identified during 1993–2016. The autoantigen, defined in mouse brain lysate by Western blot and mass spectrometry, was confirmed by dual immunohistochemical staining using commercial antibodies. The major antigenic region was defined by Western blot using recombinant protein fragments.ResultsIgG in 95 of 96 patients’ serum or CSF (but in none of 98 healthy or disease control subjects’ serum specimens) bound to recombinant MAP1B. A minority (17.5%) of patients’ IgG also bound to MAP1A. PCA‐2 was often accompanied by additional neural autoantibody markers of small‐cell carcinoma, including collapsin response‐mediated protein 5 (CRMP5) IgG (26%) or antineuronal nuclear antibody type 1 (ANNA‐1) IgG (also known as anti‐Hu; 13%). Neurological manifestations in 95 patients were (in decreasing frequency): peripheral neuropathy, 53%; cerebellar ataxia, dysmetria, or dysarthria, 38%; and encephalopathy, 27%. Cancer (majority small‐cell lung carcinoma [SCLC]) was detected in 66 of 84 evaluated patients (79%). The MAP1B (PCA‐2) autoantibody detection rate, among approximately 70,000 patients undergoing service neural autoantibody evaluation in 2015, was 0.024%, equaling amphiphysin IgG (0.026%) and more common than ANNA‐2 (also known as anti‐Ri; 0.016%) and PCA‐Tr (also known as delta/notch‐like epidermal growth factor‐related receptor [DNER]; 0.006%).InterpretationMAP1B, the PCA‐2 autoantigen, represents a novel target in paraneoplastic neurological disorders and has high predictive value for SCLC. Its relatively high prevalence, compared with other recognized paraneoplastic neural autoantibodies, justifies its testing in comprehensive paraneoplastic neural autoantibody evaluation. Ann Neurol 2017;81:266–277
Expert Panel Assessment of Appropriateness of Abdominal Aortic Aneurysm Surgery: Global Judgement versus Probability Estimation
Silverstein, Marc D., Ballard, David

Mayo Clinic

Journal of Health Services Research & Policy | January 11, 2017 | Volume: 3 | Issue: 3 | Pages: 134-140

10.1177/135581969800300303 | PMID 10185371 Get It

Objective: To compare an expert panel's global assessment of appropriateness of elective surgery for abdominal aortic aneurysms (AAA) with their assessment of the effect of surgery on the probability of 5-year mortality. Methods: Nine expert panel members rated the appropriateness of 120 scenarios for elective AAA repair on a nine-point scale, and also estimated the 5-year probability of AAA-related death and of non-AAA related death among 30-day survivors of AAA surgery and among patients with unoperated AAA. These probabilities were used to determine differences in 5-year probability of mortality of surgery vs. no surgery for each scenario. Three categories of appropriateness were defined based on these differences: inappropriate (< 0%), equivocal (0-5%), and appropriate (>5%). Results: The distribution of scenarios was inappropriate (39%), equivocal (12%), and appropriate (49%) based on probability estimates and inappropriate (43%), equivocal (22%), and appropriate (36%) based on global assessment. There was poor agreement between the two methods, with a Kappa coefficient=0.28 (95% CI: 0.23 to 0.32). Although a higher proportion of scenarios were rated as appropriate using probability estimation rather than global judgment, the level of agreement among members of the panel was similar, Kappa coefficient= 0.07 (95% CI: — 0.07 to 0.72) Conclusions: Experts disagree about the appropriate indications for elective surgery for AAA. Explicit estimates used in a decision analysis may provide a better assessment of appropriate indications than the global judgment of experts. Global assessment of the appropriateness of AAA surgery based on panel members' review of research evidence for increased survival appears to include implicitly their valuation of outcomes.
Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation
Blancas‐Mejía, Luis M. , Misra, Pinaki , Ramı́rez-Alvarado, Marina , Ramirez-Alvarado, Marina , Misra, Pinaki

Mayo Clinic

Biochemistry | January 11, 2017 | Volume: 56 | Issue: 5 | Pages: 757-766

10.1021/acs.biochem.6b01043 | PMID 28074646 Get It

Effects of Endothelial Injury on the Rate of Thrombus Organization in Canine Carotid Arteries Occluded with Microcoils
Abruzzo, Todd , Shengelaia, George G., Cloft, Harry J. , Miller, David A. , Dion, Jacques E. , Workman, Michael J.

Mayo Clinic

Interventional Neuroradiology | January 11, 2017 | Volume: 9 | Issue: 1 | Pages: 7-19

10.1177/159101990300900102 | PMID 20591298 Get It

Thrombus organization in canine carotid arteries occluded with platinum microcoils was studied to determine if endothelial injury created with a Xenon Chloride Excimer Laser (XEL) could acclerate endovascular fibrosis. Ten common carotid artery stumps were created in ten dogs. Each of four stumps were schematically divided into four longitudinally contiguous injury zones (thermal ablation injury, non-ablative injury, proximal and distal non-injury zones) to test the effects of ablative and non-ablative injury and to establish a set of internal controls that would account for proximity to circulating blood at the ostium of the occluded artery. Following XEL irradiation of the endothelium through an arteriotomy, each stump was embolized with microcoils. Four control stumps were subjected to sham laser procedures, and embolized in an identical fashion. Two additional stumps were embolized in the absence of sham surgery. Angiographic, gross and histologic analysis was performed after four weeks. Specimens of freshly clotted whole blood mixed with microcoils were used as an additional control. In irradiated stumps and non-irradiated stumps (sham and embolization only), angiography revealed no evidence of coil compaction or recanalization. In all irradiated stumps the thermal ablation zone contained fibrous tissue and neovascularity without unorganized thrombus. The other zones in the irradiated stumps were indistingnishable from each other and from all zones in the non-irradiated sham stumps, containing primarily unorganized thrombus. Stumps embolized in the absence of sham surgery were filled with material that was grossly and microscopically identical to specimens of freshly clotted whole blood containing microcoils. The results indicate that thermal ablation injury of the endothelium accelerates thrombus organization in canine carotid arteries occluded with platinum microcoils.
Extracorporeal Membrane Oxygenation in Severe Influenza Infection with Respiratory Failure: A Systematic Review and Meta-analysis
Sukhal, Shashvat , Sethi, Jaskaran , Ganesh, Malini, Villablanca, Pedro , Malhotra, Anita K., Ramakrishna, Harish

Mayo Clinic

Annals of Cardiac Anaesthesia | January 10, 2017 | Volume: 20 | Issue: 1 | Pages: 14-21

10.4103/0971-9784.197820 | PMID 28074789 Get It

Introduction: Extracorporeal membrane oxygenation (ECMO) has been extensively used for potentially reversible acute respiratory failure associated with severe influenza A (H1N1) pneumonia; however, it remains an expensive, resource-intensive therapy, with a high associated mortality. This systematic review and meta-analysis aims to summarize and pool outcomes data available in the published literature to guide clinical decision-making and further research. Methods: We conducted a systematic search of MEDLINE (1966 to April 15, 2015), EMBASE (1980 to April 15, 2015), CENTRAL, and Google Scholar for patients with severe H1N1 pneumonia and respiratory failure who received ECMO. The study validity was appraised by Newcastle–Ottawa Scale. The primary outcome was all-cause mortality. The secondary outcomes were duration of ECMO therapy, mechanical ventilation, and Intensive Care Unit (ICU) length of stay. Results: Of 698 abstracts screened and 142 full-text articles reviewed, we included 13 studies with a total of 494 patients receiving ECMO in our final review and meta-analysis. The study validity was satisfactory. The overall mortality was 37.1% (95% confidence interval: 30–45%) limited by underlying heterogeneity ( I 2 = 65%, P value of Q statistic = 0.006). The median duration for ECMO was 10 days, mechanical ventilation was 19 days, and ICU length of stay was 33 days. Exploratory meta-regression did not identify any statistically significant moderator of mortality ( P < 0.05), except for the duration of pre-ECMO mechanical ventilation in days (coefficient 0.19, standard error: 0.09, Z = 2.01, P < 0.04, R 2 = 0.16). The visual inspection of funnel plots did not suggest the presence of publication bias. Conclusions: ECMO therapy may be used as an adjunct or salvage therapy for severe H1N1 pneumonia with respiratory failure. It is associated with a prolonged duration of ventilator support, ICU length of stay, and high mortality. Initiating ECMO early once the patient has been instituted on mechanical ventilation may result in improved survival.
Role Development of Nurse Practitioners and Physician Assistants in Liver Transplantation
Chaney, Amanda , Harnois, Denise M. , Musto, Kaitlyn R., Nguyen, Justin H. , Chaney, Amanda J

Mayo Clinic

Progress in Transplantation | January 10, 2017 | Volume: 26 | Issue: 1 | Pages: 75-81

10.1177/1526924816632116 | PMID 27136253 Get It

Background: Nurse practitioners (NPs) and physician assistants (PAs) are increasingly utilized in health care. However, their roles in liver transplantation (LT) have not been investigated. Materials and Methods: In this study, we reviewed the employment and development of NPs and PAs and their impact on our deceased-donor LT (DDLT) program. Results: We found a safe and efficient way to utilize NPs and PAs in a DDLT program. Since the beginning of our program, Model of End-Stage Liver Disease (MELD) scores have increased significantly, suggesting patients are sicker at the time of transplant, and wait times of patients have become longer. With the incorporation of NPs and PAs, we found that length of stay (LOS) was not affected. The overall median warm ischemic time did not increase. Outcomes of LT for both patient and graft survival actually improved and remain at or above the expected values. These results collectively support the usefulness and validity of NPs and PAs in a DDLT program. Conclusion: We have determined that surgical and medical NPs and PAs are essential for optimal patient outcomes. They facilitate a better learning experience for residents and fellows on their transplant rotations. Further investigations to assess the roles of these providers and their impact on the education of residents and fellows in transplantation are warranted. Further transplant hepatology education programs and/or fellowships are recommended to assist in the education and professional development of transplant NPs and PAs.
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma
Merryman, Reid W. , Zinzani, Pier Luigi , Carlo‐Stella, Carmelo , Ansell, Stephen M. , Perales, Miguel-Angel, Avigdor, Abraham, Halwani, Ahmad , Houot, Roch, Marchand, Tony , Dhédin, Nathalie , Lescaut, W., Thiebaut‐Bertrand, Anne , François, Sylvie, Stamatoullas‐Bastard, Aspasia, Rohrlich, Pierre-Simon, Wallet, Hélène Labussière, Castagna, Luca , Santoro, Armando , Bachanová, Veronika , Bresler, Scott C., Kim, Harim , Pesek, Emily, Chammas, Marie J, Reynolds, Carol, Ho, Vincent T., Antin, Joseph H., Soiffer, Robert J. , Armand, Philippe , Kim, Haesook T. , Houot, Roch , Rohrlich, Pierre‐Simon , Bresler, Scott C. , Srivastava, Amitabh , Reynolds, Carol, Antin, Joseph H. , Ritz, Jerome , Bachanova, Veronika , Zinzani, Pier Luigi , Santoro, Armando , Castagna, Luca , Carlo-Stella, Carmelo , Merryman, Reid W

Mayo Clinic

Blood | January 10, 2017 | Volume: 129 | Issue: 10 | Pages: 1380-1388

10.1182/blood-2016-09-738385 | PMID 28073785 Get It

Key Points HSCT after PD-1 blockade is feasible, although may be associated with increased early immune toxicity. PD-1 blockade may cause persistent depletion of PD1+ T cells and alterations in T-cell differentiation impacting subsequent treatment.
Penetrating Atherosclerotic Ulcers of the Descending Thoracic Aorta May Be Managed Expectantly
Sundt, Thoralf M. , Camillo, Cynthia J., Schuessler, Richard B., Gutiérrez, Fernando R. , Absi, Tarek

Mayo Clinic

Vascular | January 10, 2017 | Volume: 12 | Issue: 5 | Pages: 307-311

10.1258/rsmvasc.12.5.307 | PMID 15768479 Get It

The natural history of penetrating atherosclerotic ulcers (PAUs) of the descending thoracic aorta remains unclear. Between January 1996 and June 2000, PAU was diagnosed in 36 patients (16 men, 20 women; mean age 74.9 ± 1.5 years) at Washington University. Imaging studies and hospital records were reviewed. Late follow-up was by search of the Social Security Death Index and telephone interview. None of 16 asymptomatic patients underwent operation. At follow-up (median 457 days), 6 patients had died of unrelated and 2 of unknown causes. Among 20 symptomatic patients, 10 had associated intramural hematoma (5) or dissection (5), of whom 3 underwent operation. At median follow-up (448 days), the 7 unoperated patients remained alive without an aortic operation. Among the remaining 10 symptomatic patients, 3 had an aortic operation and 2 died of unknown causes during follow-up (median 586 days). These data suggest that, in selected cases, PAU may be managed expectantly with careful observation.
Late Thrombogenicity of Grafts in the Venous System
Plate, G, Hollier, Larry H. , Dewanjee, Mrinal K., Kaye, Michael P.

Mayo Clinic

Phlebology: The Journal of Venous Disease | January 10, 2017 | Volume: 2 | Issue: 1 | Pages: 29-36

10.1177/026835558700200110 Get It

Although some previous experiments have demonstrated encouraging early results with venous vascular prosthesis, the long-term results have not been sufficiently investigated. The late thrombogenicity of 12 autogenous vein grafts and eight polytetrafluoroethylene (PTFE) grafts, three of which had been subjected to endothelial seeding, was evaluated 6 months after implantation in the canine venous system by determination of the survival time of the indium-labelled autogenous platelets and of the light and electron microscopic appearance of the graft-to-blood interface. Twelve dogs receiving autogenous vein grafts had a platelet half-life of 64 ± 13 (mean ± s.d.) hours and a completely thrombus-free internal graft surface covered by a smooth endothelium. The platelet half-life in five dogs with non-seeded PTFE grafts was significantly ( P < 0.01) shorter (44 ± 11h). The PTFE-to-blood interface consisted of a 100- to 170-μm-thick pseudointima with a thrombus-free surface area of 25-90% and substantial endothelial coverage in only two animals. Three dogs receiving endothelial-seeded PTFE grafts had a platelet half-life of 38, 46 and 53h, respectively, a 10- to 80-μm-thick pseudointima covered with typical endothelium, and a thrombus-free surface area of 90-100%. Our results demonstrate that PTFE grafts are still thrombogenic at 6 months following implantation in the canine venous system. Therefore, additional measures are required to maintain graft patency. Our limited experience with endothelial seeding does not allow any definite conclusions, but our findings indicate that this procedure might be beneficial.